Navigation Links
Gene Therapy Helps To Cure 'Incurable' Illness

The immune systems of two men who were born with an "incurable" genetic disorder that made them almost defenceless against bacterial and fungal infections has been repaired with Gene therapy. // Sixteen months after an operation to repair a defective gene, the once severely ill patients show signs of complete recovery, a German-based team of scientists said Sunday. Scientists believe that this latest success will lead to further operations for treating other such chronic and incurable conditions due to inheritance of defective genes. These cutting-edge techniques have mainly been used in the past to help sick children. Dorothee von Laer, gene therapy coordinator at the Georg Speyer laboratory in Frankfurt, said two males, aged 25 and 26, had been treated for a hereditary autoimmune disease over the past two years at Frankfurt University Hospital. She said the new technique might prove suitable for other diseases where people are born with a defective gene. Gene therapy is a procedure involving the alteration of a person's genome to repair or replace a mutated gene. After years research, the technique has finally seems to have proven its potential with a handful of successful operations. The treatment of two men with chronic granulomatous disorder (CGD) is the latest success. The men suffered repeated life-threatening infections from bacteria and fungi from an early age had to rely on powerful antibiotics and antifungal medicines. After their operations 16 months ago, both patients have gained weight and have been free of the severe infections that have plagued them since childhood. Manual Grez of the Institute for Biomedical Research in Frankfurt, one of the leaders of the study published in the journal Nature Medicine, said the results suggest that it may be possible to use gene therapy to treat other similar inherited diseases. Stating that the work was a landmark study he said that though the results are very positive there still has to be a lot of wor
'"/>




Page: 1 2

Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Consensus on "Combination Therapy" for Breast Cancer
3. Gene Therapy shows promise in treating Hemophilia
4. "Make AIDS Therapy affordable" - Physicians demand
5. Hormone replacement Therapy a headache
6. Simple Therapy
7. Therapy for stopping the spread of cancer cells
8. Gene Therapy Destroys Pancreatic Cancer Cells
9. Letrozole Beats Tamoxifen in Breast Cancer Therapy
10. Garlic Supplements Impede HIV Therapy
11. Gene Therapy For Cystic Fibrosis
Post Your Comments:
(Date:10/10/2008)...LE, PA The American Nurses Credentialing Center (...) as a Magnet hospital. The news came via a confer...taff who broke out with cheers and applause., GMC...itals and only 294 hospitals in the United States... hospitals are eligible for this recognition., "A...
(Date:10/10/2008)...ggests poor self-care partly to blame , ,...f Medicare beneficiaries who have diabetes, being ... according to a new study. , Publishing in th...l Medicine , researchers from the University of Wa...erage age of 75.6 years) who had diabetes and were...
(Date:10/10/2008)... Honoring excellence in the imple... Healthcare Information and Management Systems Soc...Davies Awards in the Organizational, Ambulatory an... Chicago, IL (PRWEB) October 1...on of electronic health records (EHRs), the Healt...
(Date:10/10/2008)...YORK, Oct. 10 /PRNewswire/ -- The Johns Hopkins Un...ultimedia educational program,"Optimizing Adjuvan...atment,Selection," to present recent key research ...ment., In recent years, advancements in the treat... and biologic treatment combinations that are,incr...
Breaking Medicine News(10 mins):Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2
...DS has been haunting man for many years. There is ...as the disease is fatal and result in death. But n...led//, as they have been successful in determining...ase. HIV is a deadly RNA virus that renders man...
... States has asked the US Food and Drug Administrat...reatment of Attention Deficit Hyperactivity Disord.../ causes cardiovascular diseases such as strokes ... starting of february to review the safety of ADHD...
...study published in today's issue of the journal Na...d by Jane Visvader, of the Walter and Eliza Hall I...ated a stem cell from the breast pads in female mi...ast cancer treatments and reconstructive surgery. ...
...ters of the Communist Party of India-Marxist (CPI-...uary 2006. The supporters of the guru are // rep...Brinda Karat, who leveled charges that the medicin...ody parts. The police have detained 30 of Ramdev’s...
Other Medicine News:
(Date:10/8/2008)... Cornell University Food Scientists Expand Te...dant Activity Assay, PORTLAND, Maine, Oct. 8 /PRN...vanced today with the release of results from a ne...zen other commonly consumed,fruits like apples, ba...test using the Cellular Antioxidant Activity (CAA)...
(Date:10/8/2008)... LYON, France, Oct. 8 /- Vical Inc...anded clinical data and new nonclinical data,demon...may be broadly,applicable in DNA- and protein-base...ncer vaccines. Alain P. Rolland, Pharm.D., Ph.D., ...nt, will present the data today,Wednesday, Octobe...
(Date:10/7/2008)... FLINT, Mich., Oct. 7 /- McLaren H...e gathering some of the world,s leading medical,mi...lobe on breast and,gastrointestinal cancer treatme... and GLCI, was organized by McLaren,s Sukamal Saha... work in sentinel node mapping for,colorectal canc...
(Date:10/7/2008)... Results of FLEXX Trial Presented at the Osteoa...ld Congress, PARSIPPANY, N.J., Oct. 7 /PRNewswire...ed results from the FLEXX Trial of Osteoarthritis ...yaluronate), a highly pure,non-avian high molecula...IA-HA), is superior to intra-articular saline (IA-...
Breaking Medicine Technology:Wild Blueberries Take Top Spot in New Antioxidant Research Study 2Wild Blueberries Take Top Spot in New Antioxidant Research Study 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 2Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 4Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 5News Media Advisory: World's Leading Surgical Oncologists to Gather at McLaren Regional Medical Center to Present Latest Work on Breast, Gastrointestinal Cancer Treatments 2Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 2Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 3Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 4BioMS Medical to present at EQUITIES Conference 4625 1BioMS Medical to present at EQUITIES Conference 4625 2Pill Reduces Relapses in MS Patients 16900 1Pill Reduces Relapses in MS Patients 16900 2Draft National Toxicology Program Report Supports Safety of Bisphenol A 16895 1Draft National Toxicology Program Report Supports Safety of Bisphenol A 16895 2CV Therapeutics Announces 24185 Million Transaction with TPG Axon Capital for Half of Royalty for Lexiscan 28TM 29 28regadenoson 29 Injection 4621 1CV Therapeutics Announces 24185 Million Transaction with TPG Axon Capital for Half of Royalty for Lexiscan 28TM 29 28regadenoson 29 Injection 4621 2CV Therapeutics Announces 24185 Million Transaction with TPG Axon Capital for Half of Royalty for Lexiscan 28TM 29 28regadenoson 29 Injection 4621 3
...Presentation of Final Phase I Monthly Implant and ...d, June 11, 2007 /PRNewswire/ -- Debiopharm,Group ...al,development specialist in oncology and serious ... Debio 9902 (formerly ZT-1) studies,for the treatm...,Association International Conference on the Preve...
...HUDDINGE, Sweden,11-Jun-2007 / Karo Bio (STO:KARO)...jectives. The 12 week proof,of concept phase II st...been successfully completed. KB2115 is efficacious...range of parameters,reflecting effects on heart, b...mone receptor (TR) is a key regulator of,metabolic...
Other Medicine Technology:Clinical Update - Debio 9902 (ZT-1) for Alzheimer's Disease 2Clinical Update - Debio 9902 (ZT-1) for Alzheimer's Disease 3Karo Bio Announces Sucessfule Phase II Results of KB2115 2Karo Bio Announces Sucessfule Phase II Results of KB2115 3
Heavy. 7.5 mm curved tip.
Delicate Desmarres lid retractors, round serrated handle, very thin blades, polished finish, size 1.
Size 4 - 2.25 mm
The Catalyst system introduces a new level of computer enhanced precision to microsurgical instrumentation. It has an easy to use digital design with advanced microcomputer control of modules and is
Medicine Products: